Associated Papers
Common Variants of the OPG gene Are Associated with Osteoporosis Risk: A Meta-Analysis.
Li X et al.
Genetic Testing and Molecular Biomarkers, 2021
Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis.
Wu J et al.
Bioscience Reports, 2020
[Polymorphisms of T149C and T950C genes in osteoprotegerin promoter sites and the relationship between serum osteoprotegerin levels and coronary heart disease].
Zhao F et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2019
Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis.
Li S et al.
Plos One, 2017
Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population.
Zhou J et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2016
Association of OPG gene polymorphism with susceptibility to rheumatoid arthrits in Chinese Han.
Cai YM et al.
Immunology Letters, 2015
Role of osteoprotegerin gene variants in early-onset severe pre-eclampsia.
Yang Y et al.
The Journal of Obstetrics and Gynaecology Research, 2015
Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran.
Hashemi M et al.
International Journal of Hematology-oncology and Stem Cell Research, 2014
Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis.
Luo Y et al.
Genetic Testing and Molecular Biomarkers, 2014
Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis.
Guo L et al.
Dna and Cell Biology, 2014
"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
Piedra M et al.
Bmc Medical Genetics, 2011
Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density.
Vidal C et al.
Journal of Molecular Endocrinology, 2011
A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer.
Narita N et al.
Bmc Cancer, 2008
Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B et al.
Maturitas, 2005
Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin.
Daroszewska A et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2004